The Functional Longevity Summit Dallas 2026, hosted by Boston BioLife, is scheduled for May 15-17, 2026, at the Hilton Anatole in Dallas, Texas. The three-day medical education event aims to convene physicians, clinicians, and healthcare innovators at the intersection of precision medicine, regenerative therapies, and practice optimization.
According to the announcement, the summit introduces a new model for medical conferences by offering a clinical and operational training environment focused on practical implementation, revenue and profit optimization, and the integration of multiple modalities into cohesive treatment systems. The curriculum covers advanced diagnostics, personalized therapies, regenerative medicine, energy-based modalities, and practice integration. The goal is to equip providers with actionable strategies that improve patient outcomes and business performance while closing the gap between technology exposure and sustainable adoption.
Boston BioLife emphasizes that the summit is a practitioner-focused educational platform advancing precision, functional, and regenerative medicine through immersive, hands-on training. By combining clinical education with real-world implementation and business strategy, the summit is designed to help providers translate innovation into measurable patient outcomes and scalable practice growth.
The event comes at a time when the healthcare industry is increasingly shifting toward personalized approaches. The integration of precision medicine—which tailors treatment based on individual genetic, environmental, and lifestyle factors—has been shown to improve efficacy and reduce adverse effects. However, adoption remains challenging due to the complexity of incorporating advanced diagnostics and therapies into existing practice workflows. The summit aims to address these barriers by providing practical tools and strategies for implementation.
For more information, the full announcement is available here.
